Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680381 · ClinicalTrials.gov registry record · Phase 1
Transitional Treatment of Adolescents in Family Therapy
A Phase 1 study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT00680381: Completed Phase 1 study, sponsored by Oregon Research Institute.
NCT00680381 is a Phase 1 study that has completed, run by Oregon Research Institute. The registered enrollment target is 90 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00680381, a Phase 1 study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.
Interventions
- BEHAVIORAL MTI, Minimal Transitional Intervention
- BEHAVIORAL GTI, Group Transitional Intervention
- BEHAVIORAL STI, Systems Transitions Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2004-01 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
What the finished NCT00680381 record still lists
NCT00680381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 3 interventions - of which MTI, Minimal Transitional Intervention is the first listed.
NCT00680381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00680381 about?
NCT00680381 is a clinical study titled "Transitional Treatment of Adolescents in Family Therapy". The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then t...
What is the current status of trial NCT00680381?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2004-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00680381?
The interventions under investigation include: MTI, Minimal Transitional Intervention (BEHAVIORAL), GTI, Group Transitional Intervention (BEHAVIORAL), STI, Systems Transitions Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00680381?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00680381's enrollment target sits among peer trials
90 628th of 2000 higher than 1,352 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia